|
|
|
|
Science Sparks @ ACTREC
|
 22 June 2026 |
Vol. No. 15 ; Issue No.740 |
|
|
Publications
|
|
1. Baderiya D, Kothari A, Deshpande AD, Vidya R, Bipte S, Yadav SK, Sharma DB, Sharma D, Jha C, Kumar C, Hoysal DR, Agarwal G, Agrawal S, Devanhalli V. (2026). Evaluation of Surgeons' Perspectives and Perceived Readiness to Adopt Minimally Invasive Breast Surgery in a Low- and Middle-Income Setting. World Journal of Surgery
2. Das A, Bisen V, Dhurandhar Y, Bodakhe SH, Varma AK, Misra G, Namdeo KP (2026). Clusterin in head and neck squamous cell carcinoma: diagnostic, prognostic, and therapeutic implications. Current Oncology Reports. 28(1):68.
3. Jose M, Sable S, Wadasadawala T, Sarin R, Pathak R, Krishnamurthy R, Joshi S, Shankhdhar V, Jaiswal D, Mathews S, Mantri M. Safety and early outcomes of immediate autologous breast reconstruction in advanced breast cancer: An Indian experience. European Journal of Breast Health. 22(3):285-293.
4. Oak A, Cheulkar S, K. Sivaranjini, John R, Jadhav M, Patil D, Dashmukhe E, Patil A, Wankhade S, Gode P, Thakadiyil A, Balasubramanium G, Mishra G, Dikshit R, Chaturvedi P, Gupta S (2026). Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India. Frontiers in Oncology.
Thesis
Anjali Singh. 2026. Elucidation of Chromatin Modifiers in Differential Response of Gastrointestinal Cancer Cells to Therapy ( LIFE09201904014) (Guide: Dr. Sanjay Gupta)
|
|
|
|
|
Interesting Reads
|
|
Mina R, Beksac M, Rodríguez-Otero P, Chen W, Mateos MV, Li J, Moreau P, Cohen YC, Min CK, Jelinek T, Ye JC, Magen H, Rubinstein SM, Fu W, Hungria V, Cengiz Seval G, Farias JS, Radocha J, Maral S, Turgut M, Koh Y, O'Leary D, Schmidt Filho J, Thertulien R, An G, Huang SY, Grosicki S, Tyczyńska A, Banerjee R, Pianko MJ, Martínez-López J, Steckiewicz P, Maruyama D, Fukushima K, Oriol A, Lopez Pardo J, Goldschmidt H, Pawlyn C, Perrot A, Zamagni E, Dimopoulos MA, Rasche L, Tolbert J, Terry W, Courtoux C, Liu X, Vasey SY, Connors K, Festa M, Heuck C, Langlois A, O'Rourke L, Zhou J, Qin X, Lu J, Gong J, Vieyra D, Voorhees PM MonumenTAL-3 Investigators (2026). Talquetamab-Daratumumab in Relapsed or Refractory Myeloma. N Engl J Med.
|
|
|
Video of the Week
|
|
| Advances in Gastointestinal Cancer: Recent Updates and Future Directions |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2007, FDA approved Nexavar (sorafenib) for primary liver cancer, making it the only drug approved for liver cancer.
|
|
|
|
Cancer News
|
| |
|
New biomarker predicts gastric cancer outcomes from CT scans
|
|
News-Medical, 16/06/2026
|
|
Researchers have identified a new biomarker that may help determine the prognosis for patients with gastric cancer, the fifth most common type of cancer worldwide. The team identified a variable that combines data on the radiodensity of visceral fat and muscle by analyzing images from...
|
| |
|
Silicon-slide imaging could speed cancer diagnosis with 99% agreement, no dyes needed.
|
|
MedicalXpress, 15/06/2026
|
|
The platform was evaluated using tissue samples from 120 patients, where researchers compared its performance against conventional pathology methods. The results showed strong agreement in how healthy and cancerous tissue features were identified, supporting further validation of the approach in clinical settings...
|
|
|
|
|
| |
|
|
|
Researchers find potential therapeutic target against cancer.
|
|
EurekAlert, 18/06/2026
|
|
The experiments conducted on adherent aortic endothelial cells from rabbits cultured in a laboratory setting, the researchers observed that fewer than 5% survived disruption of adhesion and remained alive in suspension...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
